Mitochondrial DNA-targeted therapy: A novel approach to combat cancer
Cell Insight · 2023-08 · 2 (4) · 100113
DOI: 10.1016/j.cellin.2023.100113 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Insight, 2023-08. Verfasst von Yumeng Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Research Unit of Oral Carcinogenesis and Management, Chin…. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Università di Pisa, National Natural Science Foundation of China, Science and Technology Department of Sichuan Province.
Abstract (Originalsprache)
Mitochondrial DNA (mtDNA) encodes proteins and RNAs that are essential for mitochondrial function and cellular homeostasis, and participates in important processes of cellular bioenergetics and metabolism. Alterations in mtDNA are associated with various diseases, especially cancers, and are considered as biomarkers for some types of tumors. Moreover, mtDNA alterations have been found to affect the proliferation, progression and metastasis of cancer cells, as well as their interactions with the immune system and the tumor microenvironment (TME). The important role of mtDNA in cancer development makes it a significant target for cancer treatment. In recent years, many novel therapeutic methods targeting mtDNA have emerged. In this study, we first discussed how cancerogenesis is triggered by mtDNA mutations, including alterations in gene copy number, aberrant gene expression and epigenetic modifications. Then, we described in detail the mechanisms underlying the interactions between mtDNA and the extramitochondrial environment, which are crucial for understanding the efficacy and safety of mtDNA-targeted therapy. Next, we provided a comprehensive overview of the recent progress in cancer therapy strategies that target mtDNA. We classified them into two categories based on their mechanisms of action: indirect and direct targeting strategies. Indirect targeting strategies aimed to induce mtDNA damage and dysfunction by modulating pathways that are involved in mtDNA stability and integrity, while direct targeting strategies utilized molecules that can selectively bind to or cleave mtDNA to achieve the therapeutic efficacy. This study highlights the importance of mtDNA-targeted therapy in cancer treatment, and will provide insights for future research and development of targeted drugs and therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, Research Unit of Oral Carcinogenesis and Management, Chinese Academy of Medical Sciences, West China Hospital of Stomatology, S…
Förderung
- Università di Pisa
- National Natural Science Foundation of China
- Science and Technology Department of Sichuan Province
Zitieren
APA
Lin, Y., Yang, B., Huang, Y., Zhang, Y., Jiang, Y., Ma, L., & Shen, Y. Q. (2023). Mitochondrial DNA-targeted therapy: A novel approach to combat cancer. Cell Insight, 2(4), 100113. https://doi.org/10.1016/j.cellin.2023.100113
Vancouver
Lin Y, Yang B, Huang Y, Zhang Y, Jiang Y, Ma L, et al. Mitochondrial DNA-targeted therapy: A novel approach to combat cancer. Cell Insight. 2023;2(4):100113. doi:10.1016/j.cellin.2023.100113
BibTeX
@article{Lin2023,
author = {Lin, Yumeng and Yang, Bowen and Huang, Yibo and Zhang, You and Jiang, Yu and Ma, Longyun and Shen, Ying-Qiang},
title = {Mitochondrial DNA-targeted therapy: A novel approach to combat cancer},
journal = {Cell Insight},
year = {2023},
volume = {2},
number = {4},
pages = {100113},
doi = {10.1016/j.cellin.2023.100113}
}
EUVIMED